| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |